Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for prevention of pericardial effusion after CABG
IRCT20211221053477N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jan 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pericardial effusion and pericarditis comparing Colchicine with Placebo control (2 arms). Primary endpoint: Pericardial effusion. Started Jan 2022; status: completed.
02
Drugs
colchicine
03
Conditions
pericardial effusionpericarditis
Beyond the preview
Go deeper on IRCT20211221053477N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211221053477N1.